Phase 3 multi-center, double-blind, randomized, parallel group, forced titration study of the efficacy, safety, and tolerability of torcetrapib/atorvastatin compared to fenofibrate in subjects with Fredrickson type IIB dyslipidemia (mixed hyperlipidemia)
Phase of Trial: Phase III
Latest Information Update: 05 Nov 2005
At a glance
- Drugs Fenofibrate; Torcetrapib/atorvastatin
- Indications Hyperlipidaemia
- Focus Registrational; Therapeutic Use
- 05 Nov 2005 New trial record.